Gel Injection for VUR is Highly Effective Treatment

Document Sample
Gel Injection for VUR is Highly Effective Treatment Powered By Docstoc
					                                                                                    www.renalandurologynews.com      FEBRUARY 2010      Renal & Urology News 29



Gel Injection for VUR is Highly Effective Treatment
ENDOSCOPIC injection of non-animal-        this approach by a single surgeon at     undergo a VCUG, leaving an efficacy        after a single treatment, according to
stabilized hyaluronic acid/dextranomer     the Baylor College of Medicine in        population of 166 patients. In this       a report in Urology (2009; published
gel (HA/Dx) is a highly effective treat-   Houston. At least two after treat-       group, the surgeon, Michael H. Hsieh,     online ahead of print). After a second
ment for vesicoureteral reflux (VUR) in     ment, patients were to return for a      MD, PhD, who is now at Stanford           treatment, the proportions increased
children and should be considered as a     voiding cystourethrogram (VCUG)          School of Medicine in Stanford, Calif.,   to 89.6% and 95.6%, respectively.
first-line treatment option.                assessment.                              treated 265 ureters (252 refluxing and     After a third treatment, the propor-
  Researchers studied 178 children with      After initial treatment, 12 patients   13 non-refluxing). Reflux resolved in       tions rose slightly to 90.2% and 96%.
VUR (mean age 4.2 years) treated with      were lost to follow-up or had yet to     81.9% of subjects and 86.4% of ureters    The procedures were associated with
                                                                                                                              few complications.
                                                                                                                                HA/Dx gel became the first material
                                                                                                                              approved by the FDA for endoscopic
                                                                                                                              injection in children with grade 2-4 VUR,
                                                                                                                              the authors noted. Endoscopic injection
                                                                                                                              of the gel usually is performed on an
                                                                                                                              outpatient basis. It requires no incision
                                                                                                                              and can be performed quickly. ■




                                                                                                                               Lead May
                                                                                                                               Have a Role
                                                                                                                               In Bladder
                                                                                                                               Cancer
                                                                                                                               LEAD EXPOSURE may be associated
                                                                                                                               with the initiation and development of
                                                                                                                               bladder cancer, according to a study
                                                                                                                               conducted in Poland.
                                                                                                                                 A team led by Tomasz Golabek, MD,
                                                                                                                               now with Mercy University Hospital in
                                                                                      
				
DOCUMENT INFO
Description: A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
BUY THIS DOCUMENT NOW PRICE: $6.95 100% MONEY BACK GUARANTEED
PARTNER ProQuest LLC
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.